Dr. Felker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-684-8111
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1999 - 2002
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1998 - 1999
- Johns Hopkins UniversityResidency, Internal Medicine, 1993 - 1996
- Duke University School of MedicineClass of 1993
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- NC State Medical License 1999 - 2025
- MD State Medical License 1996 - 2000
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Mobile Health Behavioral Intervention in Patients With Heart Failure and Diabetes Mellitus Start of enrollment: 2017 Aug 02
Publications & Presentations
PubMed
- 1 citationsImplications of trial eligibility in patients with heart failure with mildly reduced or preserved ejection fraction.Anthony E Peters, Robert M Clare, Karen Chiswell, Josephine Harrington, Anita Kelsey
ESC Heart Failure. 2024-10-01 - 4 citationsEndpoint adjudication in cardiovascular clinical trials.Muhammad Shahzeb Khan, Muhammad Shariq Usman, Harriette G C Van Spall, Stephen J Greene, Omar Baqal
European Heart Journal. 2023-12-07 - 2 citationsOmecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HF.David E Lanfear, Joyce N Njoroge, Kirkwood F Adams, Inder Anand, James C Fang
JACC. Heart Failure. 2023-05-01
Journal Articles
- Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): A Phase 2, Pharmacokinetic, Randomised, Placebo-Controlled TrialG. Michael Felker, John R. Teerlink, The Lancet
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: